CJ-40002

· HK inno.N Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CJ-40002, covering 2016-12-29 to 2016-12-29. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK, PD, ADA of Escalating Single Dose of CJ-40002 in Healthy Male Subjects [Phase 1]